Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated:  3/21/2018
Atrium Medical Center - Middletown Regional Hospital
mi
from
Franklin, OH
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated: 3/21/2018
Atrium Medical Center - Middletown Regional Hospital
mi
from
Franklin, OH
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated:  3/21/2018
Wayne Hospital
mi
from
Greenville, OH
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated: 3/21/2018
Wayne Hospital
mi
from
Greenville, OH
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated:  3/21/2018
Kettering Medical Center
mi
from
Kettering, OH
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated: 3/21/2018
Kettering Medical Center
mi
from
Kettering, OH
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated:  3/21/2018
Upper Valley Medical Center
mi
from
Troy, OH
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated: 3/21/2018
Upper Valley Medical Center
mi
from
Troy, OH
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated:  3/21/2018
Greene Memorial Hospital
mi
from
Xenia, OH
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated: 3/21/2018
Greene Memorial Hospital
mi
from
Xenia, OH
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated:  3/21/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated: 3/21/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated:  3/21/2018
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
A Phase II Study of MK-2206 in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Status: Enrolling
Updated: 3/21/2018
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated:  3/21/2018
Swedish Medical Center Cancer Institute
mi
from
Seattle, WA
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated: 3/21/2018
Swedish Medical Center Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated:  3/21/2018
Swedish Cancer Institute Edmonds Campus
mi
from
Edmonds, WA
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated: 3/21/2018
Swedish Cancer Institute Edmonds Campus
mi
from
Edmonds, WA
Click here to add this to my saved trials
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated:  3/21/2018
Swedish Cancer Institute Issaquah Campus
mi
from
Issaquah, WA
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated: 3/21/2018
Swedish Cancer Institute Issaquah Campus
mi
from
Issaquah, WA
Click here to add this to my saved trials
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated:  3/21/2018
Pacific Gynecology Specialists
mi
from
Seattle, WA
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated: 3/21/2018
Pacific Gynecology Specialists
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated:  3/21/2018
Swedish Cancer Institute Ballard Campus
mi
from
Seattle, WA
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Phase Ib With Expansion of Patients at the MTD Study of Olaparib Plus Weekly (Metronomic) Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Patients
Status: Enrolling
Updated: 3/21/2018
Swedish Cancer Institute Ballard Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated:  3/21/2018
University of Chicago Medical Center SC
mi
from
Chicago, IL
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated: 3/21/2018
University of Chicago Medical Center SC
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated:  3/21/2018
Karmanos Cancer Institute Wayne St Karmanos
mi
from
Detroit, MI
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated: 3/21/2018
Karmanos Cancer Institute Wayne St Karmanos
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated:  3/21/2018
Sarah Cannon Research Institute Dept of Onc
mi
from
Nashville, TN
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated: 3/21/2018
Sarah Cannon Research Institute Dept of Onc
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated:  3/21/2018
University of Texas/MD Anderson Cancer Center Dept of Onc.
mi
from
Houston, TX
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated: 3/21/2018
University of Texas/MD Anderson Cancer Center Dept of Onc.
mi
from
Houston, TX
Click here to add this to my saved trials
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated:  3/21/2018
Novartis Investigative Site
mi
from
Westmead,
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated: 3/21/2018
Novartis Investigative Site
mi
from
Westmead,
Click here to add this to my saved trials
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated:  3/21/2018
Highlands Oncology Group, P.A.
mi
from
Fayetteville, AR
Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
Status: Enrolling
Updated: 3/21/2018
Highlands Oncology Group, P.A.
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Status: Enrolling
Updated:  3/21/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Status: Enrolling
Updated: 3/21/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Hazelrig-Salter Radiation Oncology Center
mi
from
Birmingham, AL
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Hazelrig-Salter Radiation Oncology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Veterans Affairs Medical Center - Long Beach
mi
from
Long Beach, CA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Veterans Affairs Medical Center - Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Radiological Associates of Sacramento Medical Group, Incorporated
mi
from
Sacramento, CA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Radiological Associates of Sacramento Medical Group, Incorporated
mi
from
Sacramento, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Washington Cancer Institute at Washington Hospital Center
mi
from
Washington,
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Washington Cancer Institute at Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Bay Medical
mi
from
Panama City, FL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Bay Medical
mi
from
Panama City, FL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Oncology Center at Saint Margaret Mercy Healthcare Center
mi
from
Hammond, IN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Oncology Center at Saint Margaret Mercy Healthcare Center
mi
from
Hammond, IN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Cancer Center at Ball Memorial Hospital
mi
from
Muncie, IN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Cancer Center at Ball Memorial Hospital
mi
from
Muncie, IN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Providence Medical Center
mi
from
Kansas City, KA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Providence Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Menorah Medical Center
mi
from
Overland Park, KA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Menorah Medical Center
mi
from
Overland Park, KA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Johnson County Radiation Therapy
mi
from
Overland Park, KA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Johnson County Radiation Therapy
mi
from
Overland Park, KA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Shawnee Mission Medical Center
mi
from
Shawnee Mission, KA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Shawnee Mission Medical Center
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Lucille P. Markey Cancer Center at University of Kentucky
mi
from
Lexington, KY
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Lucille P. Markey Cancer Center at University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Greenebaum Cancer Center at University of Maryland Medical Center
mi
from
Baltimore, MD
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Greenebaum Cancer Center at University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Central Maryland Oncology Center
mi
from
Columbia, MD
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Central Maryland Oncology Center
mi
from
Columbia, MD
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Veterans Affairs Medical Center - Ann Arbor
mi
from
Ann Arbor, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Veterans Affairs Medical Center - Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Foote Memorial Hospital
mi
from
Jackson, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Foote Memorial Hospital
mi
from
Jackson, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Breslin Cancer Center at Ingham Regional Medical Center
mi
from
Lansing, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Breslin Cancer Center at Ingham Regional Medical Center
mi
from
Lansing, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
William Beaumont Hospital - Royal Oak Campus
mi
from
Royal Oak, MI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
William Beaumont Hospital - Royal Oak Campus
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
CentraCare Clinic - River Campus
mi
from
Saint Cloud, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
CentraCare Clinic - River Campus
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Regional Cancer Center at Singing River Hospital
mi
from
Pascagoula, MS
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Regional Cancer Center at Singing River Hospital
mi
from
Pascagoula, MS
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Independence Regional Health Center
mi
from
Independence, MO
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Independence Regional Health Center
mi
from
Independence, MO
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Truman Medical Center - Hospital Hill
mi
from
Kansas City, MO
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Truman Medical Center - Hospital Hill
mi
from
Kansas City, MO
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Saint Luke's Cancer Institute at Saint Luke's Hospital
mi
from
Kansas City, MO
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Saint Luke's Cancer Institute at Saint Luke's Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
Kansas City Cancer Center at St. Joseph's Medical Mall
mi
from
Kansas City, MO
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Kansas City Cancer Center at St. Joseph's Medical Mall
mi
from
Kansas City, MO
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
St. Joseph Medical Center
mi
from
Kansas City, MO
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
St. Joseph Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
North Kansas City Hospital
mi
from
Kansas City, MO
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
North Kansas City Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials